2018 Antitrust M&A Year in Review
Client Alert | 1 min read | 03.01.19
Crowell & Moring LLP is pleased to release its "2018 Antitrust M&A Year in Review." Following a year of significant and industry-transforming transactions, this publication provides insight and analysis into developments and trends in global antitrust enforcement of mergers and acquisitions. We examine how changes, such as the first full-year of Trump administration appointments at the Antitrust Division and the seating of five new FTC Commissioners, have impacted the U.S. antitrust agencies’ enforcement priorities and policies. We also look at merger control in the EU, which saw a record-breaking number of filings in 2018.
The report spotlights areas that were particularly noteworthy in 2018, including telecom and media, health care, and policy changes regarding vertical mergers. We also take a look at the implications of China’s regulatory activity on merger control and its role in global merger review.
Given the likelihood that recent antitrust merger enforcement developments foreshadow what to expect in the coming year, the 2018 Antitrust M&A Year in Review provides insight into trends that will be highly relevant going forward. We hope that you will find this report useful and welcome your feedback.
Click here to access the report PDF.
Contacts
Insights
Client Alert | 3 min read | 06.30.25
The New EU “Pharma Package”: Preparing for the Trilogues
On June 4, 2025, after nearly two years of intense debate and negotiation between the 27 EU Member States, the Council of the European Union adopted its position on the proposed overhaul of the EU general pharmaceutical legislative framework known as the new Pharma Package.
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
Client Alert | 3 min read | 06.26.25
Client Alert | 4 min read | 06.26.25
Ninth Circuit Affirms that CIPA Only Applies to Third-Party Eavesdropping
